Irit Avni‐Biron

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 320 citations · Full text

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

Uri Kopylov, Yulia Ron, Irit Avni‐Biron et al. · Inflammatory Bowel Diseases · 2017 · 98 citations

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Hadar Edelman-Klapper, Eran Zittan, Ariella Bar‐Gil Shitrit et al. · Gastroenterology · 2021 · 91 citations · Full text

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study

Uri Kopylov, Bram Verstockt, Luc Biedermann et al. · Inflammatory Bowel Diseases · 2018 · 68 citations